Panacea Biotec Ltd. share price target and research reports

Name: Latest research reports of Panacea Biotec Ltd. authored by Rudra Shares and Stock Brokers Ltd and published by - Trendlyne research reports.
Item: Panacea Biotec Ltd.
Rating: 5
Author: Rudra Shares and Stock Brokers Ltd

Latest analyst research reports with target prices and PDF download for PANACEABIO, BSE:531349 Panacea Biotec Ltd.

Search Inside the pdf :

Panacea Biotec Ltd.

25 Oct 2017

413.65

2.73%

PANACEA BIOTEC LTD

Buy: Panacea Biotec Ltd.

Rudra Shares and Stock Brokers Ltd

Robust product pipeline of promising niche products to fuel long term future growth, Strong Product Portfolio with significant brand market share in respective therapeutic segment, PANACEA is amongst the top 50 innovators in India with strong foundation of over two decades. Eyeing on Recent updates & highlights Amongst 6 WHO pre-qualified Suppliers of pentavalent vaccine US ANDAs - 3 approved; 3 pending for approval; 23 under development...

Panacea Biotec has lost -24.63% in the last 1 Month

Is Panacea Biotec Ltd. worth buying?

226 Votes:

Buy 76.99%

Sell 13.72%

Hold 9.29%